<DOC>
	<DOCNO>NCT00600873</DOCNO>
	<brief_summary>R ( + ) pramipexole administer escalating dos patient early ALS . Plasma spinal fluid level R ( + ) PPX monitor , addition biochemical marker oxidative stress .</brief_summary>
	<brief_title>R ( + ) PPX High Dose Treatment ALS</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>definite ALS prior exposure R ( + ) PPX ALSFRS baseline &lt; 40 FVC baseline &lt; 70 %</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>neuroprotection</keyword>
	<keyword>oxidative stress</keyword>
</DOC>